Patents Assigned to EPOS-IASIS RESEARCH AND DEVELOPMNT, LTD
  • Prototype systems of theranostic biomarkers for in vivo molecular management of cancer
    Patent number: 10640524
    Abstract: The present invention relates to a theranostic system comprising a beacon and a compound selected from the group consisting of a quinazoline-based tyrosine kinase inhibitor and a natural product. The theranostic systems have use in the therapy and diagnosis of tyrosine kinase related malignancies.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: May 5, 2020
    Assignee: EPOS-IASIS RESEARCH AND DEVELOPMNT, LTD
    Inventors: Andreani Odysseos, Costas Pitris, Anastasios Keramidas